Penny stocks are rearing their ugly heads on Australia’s flagship S&P/ASX 200 Index with alarming regularity, in a reflection of the market’s deteriorating quality, as the ASX shrinks for the first time in 18 years.
Last week, Australia’s flagship index resembled a penny stock casino, with shares in lithium explorer Lake Resources crashing 38 per cent to 29.5¢ after it revealed a six-year delay to its Argentinian lithium project. Speculative biotech Imugene finished the week at just 8.9¢, with tech hopeful BrainChip losing 13.8 per cent over the week to 34.5¢.